Cardioprotective effect of periodontal therapy in metabolic syndrome: A pilot study in indian subjects

Metabolic Syndrome and Related Disorders

Volumn 8, Issue 4, 2010, Pages 335-341

  Acharya, Aneesha ^a   Bhavsar, Neeta ^a   Jadav, Bhavesh ^a   Parikh, Hiral ^a  

^a GOVERNMENT DENTAL COLLEGE AND HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART PROTECTION; HUMAN; INDIA; INFLAMMATION; LEUKOCYTE COUNT; MALE; METABOLIC SYNDROME X; PERIODONTAL DISEASE; PERIODONTICS; PERIODONTITIS; PRIORITY JOURNAL;

ADULT; C-REACTIVE PROTEIN; CHOLESTEROL, LDL; DEBRIDEMENT; FEMALE; GINGIVAL HEMORRHAGE; HEART DISEASES; HUMANS; INDIA; LEUKOCYTE COUNT; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PERIODONTAL DISEASES; PERIODONTITIS; PILOT PROJECTS; TRIGLYCERIDES;

EID: 77955569609     PISSN: 15404196     EISSN: None     Source Type: Journal    
DOI: 10.1089/met.2010.0002     Document Type: Article

References (45)

1. Ruderman N, Chisholm D, Pi-Sunyer X, Schneider S. The meta- bolically obese, normal-weight individual revisited. Diabetes 1998;47:699-713.
2. Gupta R, Deedwania PC, Gupta A, Rastogi S, Panwar RB, Kothari K. Prevalence of metabolic syndrome in an Indian urban population. Int J Cardiol 2004; 97:257-261.
3. Saito T, Shimazaki Y, Koga T, Tsuzuki M, Ohshima. A Relationship between upper body obesity and periodontitis . J Dent Res 2001;80:1631-1636.
4. Saito T, Shimazaki Y, Kiyohara Y, Kato I, Kubo M, Iida M, Yamashita Y. Relationship between obesity, glucose tolerance, and periodontal disease in Japanese women: The Hisayama study. J Periodontal Res 2005;40:346-353.
5. D'Aiuto F, Sabbah W, Netuveli G, Donos N, Hingorani AD, Deanfield J, Tsakos G., Association of the metabolic syndrome with severe periodontitis in a large U.S. population-based survey. J Clin Endocrinol Metab 2008;93:3989-3994.
6. Shimazaki Y, Saito T, Yonemoto K, Kiyohara Y, Iida M, Yamashita Y. Relationship of metabolic syndrome to periodontal disease in Japanese women: The Hisayama Study. J Dent Res 2007;86:271-275.
7. Kushiyama M, Shimazaki Y, Yamashita Y. Relationship between metabolic syndrome and periodontal disease in Japanese adults. J Periodontol 2009;80:1610-1615.
8. D'Aiuto F, Nibali L, Parker M, Suvan J, Tonetti MS. Short-term effects of intensive periodontal therapy on serum inflammatory markers and cholesterol. J Dent Res 2005;84:269-273.
9. Ide M, Jagdev D, Coward PY, Crook M, Barclay GR, Wilson RF. The short-term effects of treatment of chronic periodontitis on circulating levels of endotoxin, C-reactive protein, tumor necrosis factor-alpha, and interleukin-6. J Periodontol 2004;75:420-428.
10. IoannidouE,MalakzadehT,BagdzoglouA. Effect of Periodontal treatment on serum C reactive protein levels: A systematic review and meta-analysis. J Periodontol 2006;77:1635-1642
11. Iwamoto Y, Nishimura F, Soga Y, Takeuchi K, Kurihara M, Takashiba S, Murayama Y. Antimicrobial periodontal treatment decreases serum C-reactive protein, tumor necrosis factor-alpha, but not adiponectin levels in patients with chronic periodontitis. J Periodontol 2003;74:1231-1236.
12. Iacopino AM, Cutler CW. Pathophysiological relationships between periodontitis and systemic disease: recent concepts involving serum lipids. J Periodontol 2000;71:1375-1384.
13. Bullon P, Morillo JM, Ramirez-Tortosa MC, Quiles JL, Newman HN, Battino M. Metabolic syndrome, and periodontitis: Is oxidative stress a common link? J Dent Res 2009;88:503-518.
14. Bertz WA, Weyant RJ, Corby PM, Ren D, Weissfeld L, Kirtchevsky SB, Harris T, Kurella M, Satterfield S, Visser M, Newman AB. Systemic inflammatory markers, periodontal diseases, and periodontal infections in an elderly population. J Am Geriatr Soc 2005;53:1532-1537.
15. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F, American Heart Association, National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome . An American Heart Association/ National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735-2752.
16. D'Aiuto F, Sabbah W, Netuveli G, Donos N, Hingorani AD, Deanfield J, Tsakos G. Association of the metabolic syndrome with severe periodontitis in a large U.S. population-based survey. J Clin Endocrinol Metab 2008;93:3989-3994.
17. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002;288:2709-2716.
18. Li P, He L, Sha YQ, Luan QX. Relationship of metabolic syndrome to chronic periodontitis. J Periodontol 2009;80:541-549.
19. Tamakoshi K, Yatsuya H, Kondo T, Hori Y, Ishikawa M, Zhang H, Murata C, Otsuka R, Zhu S, ToyoshiHernan M.A. The metabolic syndrome is associated with elevated circulating C-reactive protein in healthy reference range, a systemic low-grade inflammatory state. Int J Obes Relat Metab Disord 2003;27:443-449.
20. Craig RG, Yip JK, So MK, Boylan RJ, Socranksy SS, Haffajee AD. Relationship of destructive periodontal disease to the acute phase response. J Periodontol 2003;74:1007-1016.
21. Noack B, Genco RJ, Trevisan M., Grossi S, Zambon JJ, De Nardin E. Periodontal infections contribute to elevated systemic C-reactive protein level. J Periodontol 2001;72:1221-1227.
22. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC, Taubert K, Tracy RP, Vinicor F. Markers of infiam- mation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107:499-511.
23. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-843.
24. Ridker PM, Buring JE, Cook NR, Rifai N. C-Reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: An 8-year follow-up of 14,719 initially healthy American women. Circulation 2003;107:391-397.
25. Bao YQ, Jia WP, Chen L, Lu JX, Xiang KS. Association between C-reactive protein level and metabolic syndrome and components thereof. Zhonghua Yi Xue Za Zhi 2006;86:2105-2109.
26. Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000;102:2165-2168.
27. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: Meta-analyses of prospective studies. JAMA 1998;279:1477-1482.
28. Sweetnam PM, Thomas HF, Yarnell JWG, Baker IA, Elwood PC. Total and differential leukocyte counts as predictors of isch- emic heart disease: The Caerphilly and Speedwell Studies. Am J Epidemiol 145:416-421.
29. Ble A, Palmieri E, Volpato S, Costantini F, Fellin R, Zuliani G. White blood cell count is associated with some features of metabolic syndrome in a very old population. Nutr Metab Cardiovasc Dis 2001;11:221-226.
30. Nagasawa N, Tamakoshi K, Yatsuya H, Hori Y, Ishikawa M, Murata C, Zhang H, Wada K, Otsuka R, Mabuchi T, Kondo T, ToyoshiHernan M.A. Association of white blood cell count and clustered components of metabolic syndrome in Japanese men. Circ J 2004;68:892-897.
31. Amar S, Gokce N, Morgan S, Loukideli M, Van Dyke TE, Vita JA. Periodontal disease is associated with brachial artery endothe- lial dysfunction and systemic inflammation. Arterioscler Thromb Vasc Biol 2003;23:1245-1249.
32. Zhu J, Quyyumi AA,Norman JE, Csako G, Waclawiw MA, Shearer GM, Epstein SE. Effects of total pathogen burden on coronary artery disease and C-reactive protein levels. Am J Cardiol 2000;85:140-146.
33. Lindy O, Suomalainen K, Makela M, Lindy S. Statin use is associated with fewer periodontal lesions: A retrospective study. BMC Oral Health 2008;8:16.
34. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: An 8-year follow-up of 14 719 initially healthy American women. Circulation 2003;107:391-397.
35. Malik S, Wong ND, Franklin S, Pio J, Fairchild C, Chen R. Cardiovascular disease in U.S. patients with metabolic syndrome, diabetes, and elevated C-reactive protein. Diabetes Care 2005;28:690-693.
36. Koenig W, Sund M, Frohlich M, Fischer HG, Lowel H, Doring A, Hutchinson WL, Pepys MB. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 1999;99:237-242.
37. Christian C, Dietrich T, Hagervald, S, Kage A, Bernimoulin, JP. White blood cell count in generalized aggressive periodontitis after non-surgical therapy. J Clin Periodontol 2002;29:201-206.
38. Loos BG. Systemic markers of inflammation in periodontitis. J Periodontol 2005;76:ll-s, 2106-2115.
39. Home BD, Anderson JL, John JM, Weaver A, Bair TL, Jensen KR, Renlund DG, Muhlestein JB; Intermountain Heart Collaborative Study Group. Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol 2005;45: 1638-1643.
40. Waterhouse D, Cahill R, Sheehan F. Prediction of calculated future cardiovascular disease by monocyte count in an asymptomatic population. Vasc Health Risk Manag 2008;4:177-187.
41. Duan JY, Ou-Yang XY, Zhou YX. Effect of periodontal initial therapy on the serum level of lipid in the patients with both periodontitis and hyperlipidemia. Beijing Da Xue Xue Bao 2009;41:36-39.
42. Behle JH, Sedaghatfar M H, Demmer RT, Wolf D L, Celenti R, Kebschull M, Belusko P B,Herrera-Abreu M, Lalla E, Papapanou PN. Heterogeneity of systemic inflammatory responses to periodontal therapy. J Clin Periodontol 2009;36:287-294.
43. D'Aiuto F, Parkar M, Brett PM, Ready D, Tonetti MS. Gene polymorphisms in pro-inflammatory cytokines are associated with systemic inflammation in patients with severe periodontal infections. Cytokine 2004;28:29-34.
44. Bullon P, Morillo JM, Ramirez-Tortosa MC, Quiles JL, Newman HN, Battino M. Metabolic syndrome and periodontitis: Is oxidative stress a common link? J Dent Res 2009;88:503-518.
45. Joy T, Lahiry P, Pollex RL, Hegele RA. Genetics of metabolic syndrome. Curr Diab Rep 2008;8:141-148.